BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wallis J, Shenton DP, Carlisle RC. Novel approaches for the design, delivery and administration of vaccine technologies. Clin Exp Immunol 2019;196:189-204. [PMID: 30963549 DOI: 10.1111/cei.13287] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 5.3] [Reference Citation Analysis]
Number Citing Articles
1 Li N, Sun Y, Fu Y, Sun K. RNA Drug Delivery Using Biogenic Nanovehicles for Cancer Therapy. Front Pharmacol 2021;12:734443. [PMID: 35002692 DOI: 10.3389/fphar.2021.734443] [Reference Citation Analysis]
2 Brooks BD, Beland A, Aguero G, Taylor N, Towne FD. Moving beyond Titers. Vaccines 2022;10:683. [DOI: 10.3390/vaccines10050683] [Reference Citation Analysis]
3 Saba K, Sameeullah M, Asghar A, Gottschamel J, Latif S, Lössl AG, Mirza B, Mirza O, Waheed MT. Expression of ESAT-6 antigen from Mycobacterium tuberculosis in broccoli: An edible plant. Biotechnol Appl Biochem 2020;67:148-57. [PMID: 31898361 DOI: 10.1002/bab.1867] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
4 Williamson ED. Vaccines for emerging pathogens: from research to the clinic. Part two. Clin Exp Immunol 2019;198:141-2. [PMID: 31625155 DOI: 10.1111/cei.13378] [Reference Citation Analysis]
5 Williamson ED. Vaccines for emerging pathogens: from research to the clinic. Clin Exp Immunol 2019;196:155-6. [PMID: 30993689 DOI: 10.1111/cei.13303] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Sunita, Sajid A, Singh Y, Shukla P. Computational tools for modern vaccine development. Hum Vaccin Immunother 2020;16:723-35. [PMID: 31545127 DOI: 10.1080/21645515.2019.1670035] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
7 Polaka S, Makwana V, Vasdev N, Sheth A, Rajpoot K, Sengupta P, Tekade RK. Engineering immunity via skin-directed drug delivery devices. Journal of Controlled Release 2022. [DOI: 10.1016/j.jconrel.2022.03.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Lemoine C, Thakur A, Krajišnik D, Guyon R, Longet S, Razim A, Górska S, Pantelić I, Ilić T, Nikolić I, Lavelle EC, Gamian A, Savić S, Milicic A. Technological Approaches for Improving Vaccination Compliance and Coverage. Vaccines (Basel) 2020;8:E304. [PMID: 32560088 DOI: 10.3390/vaccines8020304] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
9 Savina K, Sreekumar R, Soonu VK, Variyar EJ. Various vaccine platforms in the field of COVID-19. Beni-Suef Univ J Basic Appl Sci 2022;11. [DOI: 10.1186/s43088-022-00215-1] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Stentz R, Miquel-Clopés A, Carding SR. Production, Isolation, and Characterization of Bioengineered Bacterial Extracellular Membrane Vesicles Derived from Bacteroides thetaiotaomicron and Their Use in Vaccine Development. Methods Mol Biol 2022;2414:171-90. [PMID: 34784038 DOI: 10.1007/978-1-0716-1900-1_11] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Goharshadi EK, Goharshadi K, Moghayedi M. The use of nanotechnology in the fight against viruses: A critical review. Coordination Chemistry Reviews 2022;464:214559. [DOI: 10.1016/j.ccr.2022.214559] [Reference Citation Analysis]
12 Bok M, Zhao ZJ, Hwang SH, Jeong Y, Ko J, Ahn J, Lee JH, Jeon S, Jeong JH. Biocompatible All-in-One Adhesive Needle-Free Cup Patch for Enhancing Transdermal Drug Delivery. ACS Appl Mater Interfaces 2021;13:58220-8. [PMID: 34793117 DOI: 10.1021/acsami.1c18750] [Reference Citation Analysis]
13 Gupta SK, Parlane NA, Luo D, Rehm BHA, Heiser A, Buddle BM, Wedlock DN. Self-assembled particulate vaccine elicits strong immune responses and reduces Mycobacterium avium subsp. paratuberculosis infection in mice. Sci Rep 2020;10:22289. [PMID: 33339863 DOI: 10.1038/s41598-020-79407-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Pushparajah D, Jimenez S, Wong S, Alattas H, Nafissi N, Slavcev RA. Advances in gene-based vaccine platforms to address the COVID-19 pandemic. Adv Drug Deliv Rev 2021;170:113-41. [PMID: 33422546 DOI: 10.1016/j.addr.2021.01.003] [Cited by in Crossref: 34] [Cited by in F6Publishing: 23] [Article Influence: 34.0] [Reference Citation Analysis]
15 Chasaide CN, Mills KHG. Next-Generation Pertussis Vaccines Based on the Induction of Protective T Cells in the Respiratory Tract. Vaccines (Basel) 2020;8:E621. [PMID: 33096737 DOI: 10.3390/vaccines8040621] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
16 Oli AN, Obialor WO, Ifeanyichukwu MO, Odimegwu DC, Okoyeh JN, Emechebe GO, Adejumo SA, Ibeanu GC. Immunoinformatics and Vaccine Development: An Overview. Immunotargets Ther 2020;9:13-30. [PMID: 32161726 DOI: 10.2147/ITT.S241064] [Cited by in Crossref: 26] [Cited by in F6Publishing: 14] [Article Influence: 13.0] [Reference Citation Analysis]
17 Ruseska I, Fresacher K, Petschacher C, Zimmer A. Use of Protamine in Nanopharmaceuticals-A Review. Nanomaterials (Basel) 2021;11:1508. [PMID: 34200384 DOI: 10.3390/nano11061508] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
18 Carvalho VL, Long MT. Perspectives on New Vaccines against Arboviruses Using Insect-Specific Viruses as Platforms. Vaccines (Basel) 2021;9:263. [PMID: 33809576 DOI: 10.3390/vaccines9030263] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Cid R, Bolívar J. Platforms for Production of Protein-Based Vaccines: From Classical to Next-Generation Strategies. Biomolecules 2021;11:1072. [PMID: 34439738 DOI: 10.3390/biom11081072] [Reference Citation Analysis]
20 Castanha PMS, Marques ETA. A Glimmer of Hope: Recent Updates and Future Challenges in Zika Vaccine Development. Viruses 2020;12:E1371. [PMID: 33266129 DOI: 10.3390/v12121371] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
21 Vishweshwaraiah YL, Dokholyan NV. Toward rational vaccine engineering. Adv Drug Deliv Rev 2022;183:114142. [PMID: 35150769 DOI: 10.1016/j.addr.2022.114142] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
22 Denman S, Tellam R, Vuocolo T, Ingham A, Wijffels G, James P, Colditz I, Jacob R. Fleece rot and dermatophilosis (lumpy wool) in sheep: opportunities and challenges for new vaccines. Anim Prod Sci 2022;62:301-20. [DOI: 10.1071/an21120] [Reference Citation Analysis]
23 Mao L, Liu C, Liu JY, Jin ZL, Jin Z, Xue RY, Feng R, Li GC, Deng Y, Cheng H, Zou QM, Li HB. Novel Synthetic Lipopeptides as Potential Mucosal Adjuvants Enhanced SARS-CoV-2 rRBD-Induced Immune Response. Front Immunol 2022;13:833418. [PMID: 35356002 DOI: 10.3389/fimmu.2022.833418] [Reference Citation Analysis]
24 Du Y, Zhou H, Su G, Ma M, Liu Y. Protein corona-driven nanovaccines improve antigen intracellular release and immunotherapy efficacy. J Control Release 2022;345:601-9. [PMID: 35346769 DOI: 10.1016/j.jconrel.2022.03.048] [Reference Citation Analysis]
25 Pastor Y, Larrañeta E, Erhard Á, Quincooces G, Peñuelas I, Irache JM, Donnelly R, Gamazo C. Dissolving Microneedles for Intradermal Vaccination against Shigellosis. Vaccines (Basel) 2019;7:E159. [PMID: 31653077 DOI: 10.3390/vaccines7040159] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
26 Gerrard SE, Walsh J, Bowers N, Salunke S, Hershenson S. Innovations in Pediatric Drug Formulations and Administration Technologies for Low Resource Settings. Pharmaceutics 2019;11:E518. [PMID: 31597277 DOI: 10.3390/pharmaceutics11100518] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
27 Ortega-berlanga B, Pniewski T. Plant-Based Vaccines in Combat against Coronavirus Diseases. Vaccines 2022;10:138. [DOI: 10.3390/vaccines10020138] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
28 Viswanath DI, Liu HC, Huston DP, Chua CYX, Grattoni A. Emerging biomaterial-based strategies for personalized therapeutic in situ cancer vaccines. Biomaterials 2022;280:121297. [PMID: 34902729 DOI: 10.1016/j.biomaterials.2021.121297] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
29 Krajišnik D, Ilić T, Nikolić I, Savić S. Established and advanced adjuvants in vaccines' formulation: Mineral adsorbents, nanoparticulate carriers and microneedle delivery systems. Arhiv za farmaciju 2019;69:420-51. [DOI: 10.5937/arhfarm1906420k] [Reference Citation Analysis]
30 Cho CS, Hwang SK, Gu MJ, Kim CG, Kim SK, Ju DB, Yun CH, Kim HJ. Mucosal Vaccine Delivery Using Mucoadhesive Polymer Particulate Systems. Tissue Eng Regen Med 2021. [PMID: 34304387 DOI: 10.1007/s13770-021-00373-w] [Reference Citation Analysis]
31 Tellam RL, Vuocolo T, Denman S, Ingham A, Wijffels G, James PJ, Colditz IG. Dermatophilosis (lumpy wool) in sheep: a review of pathogenesis, aetiology, resistance and vaccines. Anim Prod Sci 2022;62:101. [DOI: 10.1071/an21119] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Kennedy RB, Ovsyannikova IG, Palese P, Poland GA. Current Challenges in Vaccinology. Front Immunol. 2020;11:1181. [PMID: 32670279 DOI: 10.3389/fimmu.2020.01181] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
33 Dau VT, Bui TT, Tran CD, Nguyen TV, Nguyen TK, Dinh T, Phan HP, Wibowo D, Rehm BHA, Ta HT, Nguyen NT, Dao DV. In-air particle generation by on-chip electrohydrodynamics. Lab Chip 2021;21:1779-87. [PMID: 33730135 DOI: 10.1039/d0lc01247e] [Reference Citation Analysis]
34 Pollard AJ, Bijker EM. A guide to vaccinology: from basic principles to new developments. Nat Rev Immunol 2021;21:83-100. [PMID: 33353987 DOI: 10.1038/s41577-020-00479-7] [Cited by in Crossref: 43] [Cited by in F6Publishing: 64] [Article Influence: 21.5] [Reference Citation Analysis]
35 Karpiński TM, Ożarowski M, Seremak-Mrozikiewicz A, Wolski H, Wlodkowic D. The 2020 race towards SARS-CoV-2 specific vaccines. Theranostics 2021;11:1690-702. [PMID: 33408775 DOI: 10.7150/thno.53691] [Cited by in Crossref: 48] [Cited by in F6Publishing: 40] [Article Influence: 48.0] [Reference Citation Analysis]